← Back to Search

N/A

Almond group for Immune Response (Almond Immune Trial)

N/A

Waitlist Available

Led By Joan Sabate, DrPh

Research Sponsored by Loma Linda University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12 to 20 weeks

Awards & highlights

Almond Immune Trial Summary

This trial will study the effects of eating almonds on the immunity of overweight middle-aged men, specifically how well they respond to the influenza vaccine.

Eligible Conditions

Immune Response
Inflammation

Almond Immune Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12 to 20 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12 to 20 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 to 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

changes in complete blood count (CBC)

changes in lymphocyte activity and cytokine production

changes in lymphocyte populations

+4 more

Secondary outcome measures

changes in blood vitamin E levels

changes in blood zinc levels

changes in upper respiratory infection questionnaire score

Almond Immune Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: AlmondsExperimental Treatment1 Intervention

The almond group will receive 15% of their daily energy intake in the form of almonds

Group II: PretzelPlacebo Group1 Intervention

The placebo group will receive an isocaloric carbohydrate based pretzel snack

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Almond group

2021

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor

306 Previous Clinical Trials

260,927 Total Patients Enrolled

Joan Sabate, DrPhPrincipal InvestigatorLoma Linda University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Might I satisfy the criteria to join this medical experiment?

"This research requires 54 individuals with inflammation between 40 and 65 years of age. The key eligibility criteria are as follows: Be a male with a BMI index between 25-32, meet the age limit (40-65), and live in close proximity to Loma Linda University."

Answered by AI

Are elderly participants being solicited for this clinical trial?

"The age range for this medical trial is 40 to 65, as outlined in its inclusion criteria. For patients younger than 18, there are 81 studies available and 472 trails that cater to those older than 65."

Answered by AI

What is the current enrollment size for this clinical trial?

"Correct. Per the details on clinicaltrials.gov, this medical trial is recruiting 54 participants from a single location. The research was first published on August 12th 2021 and last updated June 29th 2022."

Answered by AI

Are investigators still seeking participants for this clinical trial?

"Affirmative. According to the information posted on clinicaltrials.gov, this research project is currently searching for suitable candidates, who must come from a single location. The trial was first uploaded on 8/12/2021 and its details were last updated on 6/29/2022 with a goal of recruiting 54 patients in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Men

Joan Sabate,DrPH, MD 2021. "Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Men". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05031663.